Unknown

Dataset Information

0

Cancer selective cell death induction by a bivalent CK2 inhibitor targeting the ATP site and the allosteric αD pocket.

ABSTRACT: Although the involvement of protein kinase CK2 in cancer is well-documented, there is a need for selective CK2 inhibitors suitable for investigating CK2 specific roles in cancer-related biological pathways and further exploring its therapeutic potential. Here, we report the discovery of AB668, an outstanding selective inhibitor that binds CK2 through a bivalent mode, interacting both at the ATP site and an allosteric αD pocket unique to CK2. Using caspase activation assay, live-cell imaging, and transcriptomic analysis, we have compared the effects of this bivalent inhibitor to representative ATP-competitive inhibitors, CX-4945, and SGC-CK2-1. Our results show that in contrast to CX-4945 or SGC-CK2-1, AB668, by targeting the CK2 αD pocket, has a distinct mechanism of action regarding its anti-cancer activity, inducing apoptotic cell death in several cancer cell lines and stimulating distinct biological pathways in renal cell carcinoma.

SUBMITTER: Bancet A 

PROVIDER: S-EPMC10838953 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Although the involvement of protein kinase CK2 in cancer is well-documented, there is a need for selective CK2 inhibitors suitable for investigating CK2 specific roles in cancer-related biological pathways and further exploring its therapeutic potential. Here, we report the discovery of AB668, an outstanding selective inhibitor that binds CK2 through a bivalent mode, interacting both at the ATP site and an allosteric αD pocket unique to CK2. Using caspase activation assay, live-cell imaging, and  ...[more]

Similar Datasets

Unknown 2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.
| S-EPMC7667462 | biostudies-literature
Unknown Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.
| S-EPMC2374052 | biostudies-literature
Unknown Second-generation CK2α inhibitors targeting the αD pocket.
| S-EPMC5916021 | biostudies-literature
Unknown NMR reveals the allosteric opening and closing of Abelson tyrosine kinase by ATP-site and myristoyl pocket inhibitors.
| S-EPMC3839726 | biostudies-literature
Unknown Unique residues in the ATP gated human P2X7 receptor define a novel allosteric binding pocket for the selective antagonist AZ10606120.
| S-EPMC5429621 | biostudies-literature
Unknown Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors.
| S-EPMC10879502 | biostudies-literature
Unknown Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors.
| S-EPMC10543509 | biostudies-literature
Unknown Proposed Allosteric Inhibitors Bind to the ATP Site of CK2α.
| S-EPMC7666092 | biostudies-literature
Unknown Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors.
| S-EPMC10133702 | biostudies-literature
Unknown Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study.
| S-EPMC8037657 | biostudies-literature